Abstract #M172

# M172
Bioavailability of l-lysine sulphate compared with l-lysine·HCl to optimize performance of 12 to 25 kg pigs.
J.P. Oliveira*1, J.K. Htoo2, L. F. T. Albino1, M. I. Hannas1, R. J.B. Rodrigueiro3, N. A.A. Barbosa3, H. S. Rostagno1, 1Federal University of Viçosa, Federal University of Viçosa, Viçosa, Minas Gerais, Brazil, 2Evonik Industries AG, Evonik Industries AG, Hanau-Wolfgang, Germany, 3Evonik Industries do Brasil, Evonik Industries do Brasil, São Paulo, Brazil.

l-Lysine sulfate (Biolys), containing 54.6% l-Lys as well as other amino acids (AA) and phosphorus as fermentation co-products, is available as an alternative to l-lysine.HCl. A 21-d experiment was conducted to evaluate the relative bioavailability (RBV) on equimolar basis of Biolysrelative to l-Lys.HCl (set at 100% availability). A total of 135 barrows (PIC; initial BW of 12.46 ± 0.55kg) were assigned to 5 treatments with 9 pen replicates (3pigs/pen) for 21 d. A Lys-deficient basal diet (BD) was formulated to contain 0.57% standardized ileal digestible (SID) Lys but adequate in all other AA. The diets included (1) BD, (2) BD + 0.128% l-Lys.HCl, (3) BD + 0.256% l-Lys.HCl, (4) BD + 0.183% Biolys, and (5) BD + 0.366% Biolys. The final BW on d 21 and the overall ADG increased linearly (P < 0.01) by adding both Lys sources. Feed intake was not different but F:G improved (P < 0.01) linearly by supplementing both Lys sources. Performance responses (ADG, ADFI, F:G) of pigs fed diets supplemented with the same inclusion levels of l-Lys·HCl and Biolys were not different (P > 0.05). Using multiple linear regression and the slope ratio the RBV estimates were 104.1 and 113.3% for Biolys relative to l-Lys·HCl to optimize ADG and F:G, respectively. In conclusion, Biolysand l-Lys·HCl are equally bioavailable on equimolar basis as Lys sources for 12 to 25 kg pigs. Table 1. Performance and bioavailability (BV) of l-Lys sulfate for piglets from 12 to 25 kg1
ItemBDl-Lys HClLinearBiolysCV (%)
0.0%0.128%0.256%0.183%0.366%Linear
BW, kg223.58B24.35AB25.23A0.0124.39AB25.28A0.035.1
ADG20.530A0.566A0.608A0.010.568A0.611A0.0310.4
F:G21.921A1.730B1.685B0.011.721B1.647B0.017.1
BV of Biolys vs. l-Lys·HCl
InterceptbLHbBLBioavailability
ADG0.6340.3920.408104.1
F:G1.938–1.103–1.250113.3
A,BMeans within a row with different letters differ (P < 0.05) by the SNK test. 1Linear regression analysis; bLH = l-Lys·HCl regression coefficients; bBL = Biolys regression coefficients.

Key Words: bioavailability, l-Lys·HCl, Lys sulfate